Compare AMCR & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMCR | WAT |
|---|---|---|
| Founded | 1926 | 1958 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.4B | 22.5B |
| IPO Year | N/A | 1995 |
| Metric | AMCR | WAT |
|---|---|---|
| Price | $49.42 | $320.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 19 |
| Target Price | $53.60 | ★ $394.17 |
| AVG Volume (30 Days) | ★ 7.5M | 996.8K |
| Earning Date | 02-03-2026 | 02-09-2026 |
| Dividend Yield | ★ 5.19% | N/A |
| EPS Growth | N/A | ★ 0.47 |
| EPS | 1.47 | ★ 10.76 |
| Revenue | ★ $19,609,000,000.00 | $3,165,286,000.00 |
| Revenue This Year | $57.32 | $7.35 |
| Revenue Next Year | $1.30 | $6.39 |
| P/E Ratio | $34.03 | ★ $30.59 |
| Revenue Growth | ★ 44.82 | 6.99 |
| 52 Week Low | $38.33 | $275.05 |
| 52 Week High | $52.25 | $414.15 |
| Indicator | AMCR | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 82.36 | 24.43 |
| Support Level | $48.36 | $373.40 |
| Resistance Level | $48.85 | $337.83 |
| Average True Range (ATR) | 1.26 | 12.00 |
| MACD | -0.58 | -7.21 |
| Stochastic Oscillator | 86.63 | 16.04 |
Amcor is a global producer of plastic packaging primarily for the fast-moving consumer goods industry. About 90% of earnings are exposed to the flexible packaging business. This is soft disposable plastic for a variety of food, drink, healthcare, and hygiene products. The remainder of earnings are from the Latin and North American rigids business, which is primarily beverage bottling for the soft drink industry. Operating in more than 35 countries, Amcor has market share in its established regions of North America, Latin America, Europe, and Asia-Pacific. About half of group sales are derived from North America and the remainder is split equally between Western Europe and emerging markets. Australia and New Zealand sales make up less than 5% of group sales.
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.